Amy Vandenberg
Signal active
Vice President of Regulatory Affairs
Contact Information
Social
N/A
Primary Organization
Obalon Therapeutics
Founded
2008
Employees
51-100
Industry
Health Care, Medical, Therapeutics
Bio
Ms. VandenBerg joined Obalon in December 2008, after holding positions of increasing leadership at other medical device companies, including Cygnus and Dexcom, Inc. She has more than 15 years of experience with a focus on medical device quality systems, as well as domestic and international regulatory affairs. Ms. VandenBerg is a highly regarded regulatory professional with substantial PMA, Class IIb, and Class III CE experience.
Location
N/A
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Educations
1
Saint Marys College of California
Biology, Systemic Physiology, Genetics, Immunology, Economics, Spanish
Profile Resume
Amy Vandenberg is the Vice President of Regulatory Affairs at Obalon Therapeutics. With a background in Health Care, Amy Vandenberg has a rich history of leadership and innovation.Amy Vandenberg studied MS Biology, Systemic Physiology, Genetics, Immunology, Economics, Spanish at Saint Marys College of California. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity